Zhejiang East Asia Pharmaceutical Co Ltd (605177)

Currency in CNY
20.60
+0.28(+1.38%)
Closed·
605177 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Unusual trading volume
Fair Value
Day's Range
20.3721.14
52 wk Range
14.8022.65
Key Statistics
Bid/Ask
20.49 / 20.55
Prev. Close
20.32
Open
20.39
Day's Range
20.37-21.14
52 wk Range
14.8-22.65
Volume
4.25M
Average Volume (3m)
2.07M
1-Year Change
5.78%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
605177 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Zhejiang East Asia Pharmaceutical Co Ltd Company Profile

Zhejiang East Asia Pharmaceutical Co., Ltd. produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic agents and tumor adjuvant drugs, and other products. The company provides products in the fields of cardiovascular, anti-aging dementia, digestive system, diabetic neuropathy, and anti-pathogenic microorganisms. It serves customers through a sales network in China, Europe, the United States, Southeast Asia, and internationally. The company was founded in 1992 and is headquartered in Taizhou, China.

Employees
1749
Market
China

Compare 605177 to Peers and Sector

Metrics to compare
605177
Peers
Sector
Relationship
P/E Ratio
−17.6x−9.9x−0.5x
PEG Ratio
0.080.020.00
Price/Book
1.2x3.8x2.6x
Price / LTM Sales
2.2x4.8x3.2x
Upside (Analyst Target)
-−10.8%42.0%
Fair Value Upside
Unlock−14.1%6.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -1.17%
Dividend Yield
-
Industry Median 1.52%
Annualised payout
-
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
190.92M / --
EPS Revisions
Last 90 days

605177 Income Statement

FAQ

What Stock Exchange Does Zhejiang East Asia Pharmaceutical Co Trade On?

Zhejiang East Asia Pharmaceutical Co is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Zhejiang East Asia Pharmaceutical Co?

The stock symbol for Zhejiang East Asia Pharmaceutical Co is "605177."

What Is the Zhejiang East Asia Pharmaceutical Co Market Cap?

As of today, Zhejiang East Asia Pharmaceutical Co market cap is 2.32B.

What Is Zhejiang East Asia Pharmaceutical Co's Earnings Per Share (TTM)?

The Zhejiang East Asia Pharmaceutical Co EPS (TTM) is -1.17.

From a Technical Analysis Perspective, Is 605177 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Zhejiang East Asia Pharmaceutical Co Stock Split?

Zhejiang East Asia Pharmaceutical Co has split 0 times.

How Many Employees Does Zhejiang East Asia Pharmaceutical Co Have?

Zhejiang East Asia Pharmaceutical Co has 1749 employees.

What is the current trading status of Zhejiang East Asia Pharmaceutical Co (605177)?

As of 30 Jul 2025, Zhejiang East Asia Pharmaceutical Co (605177) is trading at a price of 20.60, with a previous close of 20.32. The stock has fluctuated within a day range of 20.37 to 21.14, while its 52-week range spans from 14.80 to 22.65.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.